FDA Clears CDC's Dengue MDx Test | GenomeWeb

NEW YORK (GenomeWeb News) – The US Food and Drug Administration has cleared for marketing a test for dengue virus developed by the US Centers for Disease Control and Prevention, CDC said today.

The test is the first FDA-approved molecular test for dengue and uses real-time PCR technology. Called the CDC DENV-1-4 Real Time RT PCR Assay, it can detect dengue within the first seven days after symptoms appear and can detect all four dengue virus types, CDC said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.